Lv1
40 积分 2025-07-07 加入
Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
11小时前
待确认
Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse
12小时前
已完结
Trends and challenges in bispecific antibody production
14天前
已完结
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study
1个月前
已完结
Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game
1个月前
已完结
Immunophenotypic Pattern of Myeloid Populations by Flow Cytometry Analysis
1个月前
已完结
CD38 as a Novel Immunosuppressive Target in Prostate Cancer
1个月前
已完结
CD38 at the junction between prognostic marker and therapeutic target
1个月前
已完结
The B7 Family Member B7-H6: a New Bane of Tumor
1个月前
已完结
The expression, function, and clinical relevance of B7 family members in cancer
1个月前
已完结
皖公网安备34019202002308
